Загрузка...
Tyrosine kinase inhibitors as induction therapy in nonsmall-cell lung cancer
TKI therapy has shown excellent efficacy and favorable tolerability in patients with mutation-positive nonsmall cell lung cancer. However, there is no clear consensus on the role of TKI as induction therapy. In this article, we reviewed recently published studies to analyze the benefits of tyrosine...
Сохранить в:
| Опубликовано в: : | Curr Opin Oncol |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Lippincott Williams & Wilkins
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7752212/ https://ncbi.nlm.nih.gov/pubmed/33165003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0000000000000696 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|